financetom
Business
financetom
/
Business
/
Form 8.3 - PRS REIT plc, The
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3 - PRS REIT plc, The
Oct 29, 2025 8:53 AM

BOSTON--(BUSINESS WIRE)--

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PRS REIT plc, The

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

28 October 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

 

1p ordinary – 549,251,458

 

Interests

 

Short Positions

 

 

 

Number

 

%

 

Number

 

%

 

(1) Relevant securities owned and/or controlled:

 

 

 

 

 

 

(2) Cash-settled derivatives:

 

11,401,602

2.08

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

 

 

 

TOTAL:

 

11,401,602

2.08

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

 

Purchase/Sale

 

Number of securities

 

Price per unit

 

N/A

N/A

N/A

N/A

 

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description e.g. CFD

 

Nature of dealing e.g. Opening/Closing a long/short position, increasing/reducing a long/short position

Number of reference securities

 

Price per unit

 

1p ordinary

 

CFD

Reducing a long position

200,000

GBP 1.1260

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Class of relevant security:

 

 

1p ordinary – 549,251,458

 

Interests

 

Short Positions

 

 

 

Number

 

%

 

Number

 

%

 

(1) Relevant securities owned and/or controlled:

 

 

 

 

 

 

(2) Cash-settled derivatives:

 

11,401,602

2.08

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

 

 

 

TOTAL:

 

11,401,602

2.08

 

 

0

Class of relevant security:

 

 

1p ordinary – 549,251,458

 

Interests

 

Short Positions

 

 

 

Number

 

%

 

Number

 

%

 

(1) Relevant securities owned and/or controlled:

 

 

 

 

 

 

(2) Cash-settled derivatives:

 

11,401,602

2.08

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

 

 

 

TOTAL:

 

11,401,602

2.08

 

 

1

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Source: Weiss Asset Management LP

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pyxis Oncology reports Q3 net loss of $22 mln
Pyxis Oncology reports Q3 net loss of $22 mln
Nov 3, 2025
Overview * Pyxis Oncology ( PYXS ) reports Q3 net loss of $22 mln, consistent with prior year * Company anticipates preliminary data from MICVO Phase 1 studies in Q4 2025 * Expected cash runway through data milestones into second half of 2026 Outlook * Pyxis Oncology ( PYXS ) expects preliminary data from MICVO studies in 4Q25 * Company...
MDA Space Invests $10 Million in Maritime Launch Services
MDA Space Invests $10 Million in Maritime Launch Services
Nov 3, 2025
07:14 AM EST, 11/03/2025 (MT Newswires) -- MDA Space ( MDALF ) said Monday that it agreed to invest C$10 million in Maritime Launch Services, which is developing Canada's first commercial orbital launch complex called Spaceport Nova Scotia. Spaceport Nova Scotia aims to provide satellite delivery services by allowing launch vehicles to place their satellites into low-earth orbit. Under the...
Krystal Biotech Q3 Earnings, Revenue Rise
Krystal Biotech Q3 Earnings, Revenue Rise
Nov 3, 2025
07:13 AM EST, 11/03/2025 (MT Newswires) -- Krystal Biotech ( KRYS ) reported Q3 earnings Monday of $2.66 per diluted share, up from $0.91 a year earlier. Two analysts polled by FactSet expected $0.95. Net product revenue for the quarter ended Sept. 30 was $97.8 million, compared with $83.8 million a year earlier. Analysts surveyed by FactSet expected $93.2 million....
Kontoor Brands Fiscal Q3 Adjusted Earnings, Net Revenue Increase; 2025 Guidance Updated
Kontoor Brands Fiscal Q3 Adjusted Earnings, Net Revenue Increase; 2025 Guidance Updated
Nov 3, 2025
07:16 AM EST, 11/03/2025 (MT Newswires) -- Kontoor Brands ( KTB ) reported fiscal Q3 adjusted earnings Monday of $1.44 per diluted share, up from $1.37 a year earlier. Analysts polled by FactSet expected $1.36. Net revenue for the quarter ended Sept. 27 was $853.2 million, compared with $670.2 million a year earlier. Analysts polled by FactSet expected $855.5 million....
Copyright 2023-2026 - www.financetom.com All Rights Reserved